IMP: BOD resolution dated July 24, 2021

The Board resolution dated July 24, 2021, the BOD of Imexpharm Corporation approved the following issues:

1)      Approving the business result in Quarter 2/2021:

-          Total revenue & other: 322.6 billion dongs

-          Net revenue: 317.4 billion dongs

-          Net profit from business activities: 60.0 billion dongs

-          Profit before tax: 61.8 billion dongs

-          Profit after tax: 49.3 billion dongs.

2)      Approving the progress report on the project of Binh Duong High Technology Plant until June 30, 2021.

3)      Approving the business plan in Quarter 3/2021.

4)      Approving the handle of bad debts with total amount of VND1,441,655,133.

HOSE

>   RIC: BOD resolution on holding EGM online (27/07/2021)

>   PLP: Decreasing the ownersip ratio at associated company (27/07/2021)

>   PHC: BOD resolution dated July 23, 2021 (27/07/2021)

>   HVN: Notice of Public Offering (27/07/2021)

>   CHPG2108: The record date for the list of holders (27/07/2021)

>   CMWG2102: The record date for rights exercise due to maturity (27/07/2021)

>   CTCH2103: The record date for the list of holders (27/07/2021)

>   CVHM2106: The record date for the list of holders (27/07/2021)

>   CPNJ2102: The record date for rights exercise due to maturity (27/07/2021)

>   CHPG2107: The record date for the list of holders (27/07/2021)